Department of Specialized Surgeries

90  articles.  
* There may be some overlapped articles listed due to the difference of format.

  1. Tabei A, Fujioka T, Kubota K, Hayashi K, Aruga T, Onishi I, Tateishi U: Breast Hemangioma with Slow Growth over 11 Years: A Case Report. Reports (MDPI). 2026.01; 9 (1): ( PubMed , DOI )

  1. Sayumi Tsuyuzaki, Tomoyuki Fujioka, Emi Yamaga, Leona Katsuta, Mio Mori, Yuka Yashima, Mayumi Hara, Arisa Sato, Iichiroh Onishi, Jitsuro Tsukada, Tomoyuki Aruga, Kazunori Kubota, Ukihide Tateishi: Evaluation of AI diagnostic systems for breast ultrasound: comparative analysis with radiologists and the effect of AI assistance. Jpn J Radiol. 2025.10; 43 (10): 1643-1651. ( PubMed , DOI )

  2. Hiroko Terui-Kohbata, Sayako Takahashi, Eriko Takamine, Mariko Komine, Maki Gau, Makiko Egawa, Yusuke Ebana, Tomoyuki Aruga, Kimio Wakana, Masayuki Yoshida: Implementation of risk-reducing surgery for HBOC under public insurance in Japan: a single-center experience. Familial Cancer. 2025.10; 24 (4): 76. ( PubMed , DOI )

  3. Tsuyuzaki Sayumi, Fujioka Tomoyuki, Yamaga Emi, Katsuta Leona, Mori Mio, Yashima Yuka, Hara Mayumi, Sato Arisa, Onishi Iichiroh, Tsukada Jitsuro, Aruga Tomoyuki, Kubota Kazunori, Tateishi Ukihide: Evaluation of AI diagnostic systems for breast ultrasound: comparative analysis with radiologists and the effect of AI assistance(タイトル和訳中) Japanese Journal of Radiology. 2025.10; 43 (10): 1643-1651. ( ichushi )

  4. Yui Innami, Yuki Mizuno, Kentaro Yamada, Kei Takasawa, Yoshifumi Ito, Kentaro Okamoto, Jun Hashimoto, Ryutaro Ohira, Konomi Shimoda, Tomoko Mizuno, Takahiro Kamiya, Toshitaka Yoshii, Masatoshi Takagi, Tomoyuki Aruga: Detorsion of Wandering Spleen Causes Significant Hypersplenism Resulting in Thrombocytopenia and Spinal Cord Injury: A Case Report. Surg Case Rep. 2025.08; 11 (1): 25-0111. ( PubMed , DOI )

  5. Hara M, Oda G, Hayashi K, Adachi M, Kumaki Y, Ishiba T, Yamaga E, Fujioka T, Nakagawa T, Mori H, Aruga T: Quantitative Analysis of Small Particles Present in Surgical Smoke Generated During Breast Surgery. Medicina (Kaunas, Lithuania). 2025.08; 61 (8): ( PubMed , DOI )

  6. Adachi Mio, Ishiba Toshiyuki, Maruya Sakiko, Hayashi Kumiko, Kumaki Yuichi, Oda Goshi, Aruga Tomoyuki: Clinical Information and Prognosis of High-risk Luminal Breast Cancer Subjects Eligible for the MonarhE Study(タイトル和訳中) JMA Journal. 2025.04; 8 (2): 486-497. ( ichushi )

  7. Adachi, M; Ishiba, T; Maruya, S; Hayashi, K; Kumaki, Y; Oda, G; Aruga, T: Clinical Information and Prognosis of High-risk Luminal Breast Cancer Subjects Eligible for the MonarhE Study JMA JOURNAL. 2025.02; 8 (2): 486-497. ( PubMed , DOI )

  8. Innami Yui, Mizuno Yuki, Yamada Kentaro, Takasawa Kei, Ito Yoshifumi, Okamoto Kentaro, Hashimoto Jun, Ohira Ryutaro, Shimoda Konomi, Mizuno Tomoko, Kamiya Takahiro, Yoshii Toshitaka, Takagi Masatoshi, Aruga Tomoyuki: Detorsion of Wandering Spleen Causes Significant Hypersplenism Resulting in Thrombocytopenia and Spinal Cord Injury: A Case Report. Surgical Case Reports. 2025; 11 (1): scrj.cr.25-0111. ( ichushi )

  9. Cardoso, F; Wuerstlein, R; Aruga, T; Haidinger, R; Lambertini, M; Benjamin, C; Valentí, EL; Criscitiello, C; Aapro, M; Grana, G; Gentry, SS; Vrdoljak, E: Underserved Patient Populations With Metastatic Breast Cancer: A Review of Progress and Remaining Challenges BREAST JOURNAL. 2025; 2025 (1): 2461234. ( PubMed , DOI )

  1. Tsukuda K, Yamamoto Y, Kazama A, Wada Y, Uchiyama H, Kikuchi T, Kudo T: Loeys-Dietz Syndrome Presenting with an Abdominal Aortic Aneurysm: A Case Report. Annals of vascular diseases. 2024.12; 17 (4): 440-442. ( PubMed , DOI )

  2. Ozaki Sara, Iwamoto Naoko, Yonekura Rika, Naito Yu, Horiguchi Shin-ichiro, Aruga Tomoyuki: 巨大な潰瘍性乳房葉状腫瘍の1例(A Case of Ulcerative Giant Phyllodes Tumor of the Breast) Dokkyo Medical Journal. 2024.12; 3 (4): 313-317. ( ichushi )

  3. Nakayama T, Niikura N, Yamanaka T, Yamamoto M, Matsuura K, Inoue K, Takahara S, Nomura H, Kita S, Yamaguchi M, Aruga T, Shibata N, Shimomura A, Ozaki Y, Sakai S, Takiguchi D, Takata T, Bastanfard A, Shiosakai K, Tsurutani J: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM). Breast cancer (Tokyo, Japan). 2024.11; 31 (6): 1167-1175. ( PubMed , DOI )

  4. Nakayama Takahiro, Niikura Naoki, Yamanaka Takashi, Yamamoto Mitsugu, Matsuura Kazuo, Inoue Kenichi, Takahara Sachiko, Nomura Hironori, Kita Shosuke, Yamaguchi Miki, Aruga Tomoyuki, Shibata Nobuhiro, Shimomura Akihiko, Ozaki Yuri, Sakai Shuji, Takiguchi Daisuke, Takata Takehiko, Bastanfard Armin, Shiosakai Kazuhito, Tsurutani Junji: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study(ROSET-BM)(タイトル和訳中) Breast Cancer. 2024.11; 31 (6): 1167-1175. ( ichushi )

  5. Nakayama T, Niikura N, Yamanaka T, Yamamoto M, Matsuura K, Inoue K, Takahara S, Nomura H, Kita S, Yamaguchi M, Aruga T, Shibata N, Shimomura A, Ozaki Y, Sakai S, Takiguchi D, Takata T, Bastanfard A, Shiosakai K, Tsurutani J: Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM). Breast cancer (Tokyo, Japan). 2024.11; 31 (6): 1184. ( PubMed , DOI )

  6. Katsuta Leona, Fujioka Tomoyuki, Kubota Kazunori, Mori Mio, Yamaga Emi, Yashima Yuka, Sato Arisa, Adachi Mio, Ishiba Toshiyuki, Oda Goshi, Nakagawa Tsuyoshi, Tateishi Ukihide: Comparison of state-of-the-art biopsy systems for ultrasound-guided breast biopsy using a chicken breast phantom(タイトル和訳中) Journal of Medical Ultrasonics. 2024.10; 51 (4): 627-633. ( ichushi )

  7. Yamaguchi Tatsuro, Ikegami Masachika, Aruga Tomoyuki, Kanemasa Yusuke, Horiguchi Shin-ichiro, Kawai Kazushige, Takao Misato, Yamada Takeshi, Ishida Hideyuki: Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan(タイトル和訳中) International Journal of Clinical Oncology. 2024.10; 29 (10): 1417-1431. ( ichushi )

  8. Ishiba, T; Nara, M; Saita, C; Kamio, H; Miyahara, K; Iwamoto, N; Hashimoto, R; Nakatsugawa, N; Adachi, M; Kumaki, Y; Oda, G; Aruga, T; Toi, M: A single-center retrospective study of 14 patients using olaparib for metastatic breast cancer ANNALS OF ONCOLOGY. 2024.10; 35 S1394-S1395. ( DOI )

  9. Yamaguchi T, Ikegami M, Aruga T, Kanemasa Y, Horiguchi SI, Kawai K, Takao M, Yamada T, Ishida H: Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan. International journal of clinical oncology. 2024.10; 29 (10): 1417-1431. ( PubMed , DOI )

  10. Yamaguchi T, Ikegami M, Aruga T, Kanemasa Y, Horiguchi SI, Kawai K, Takao M, Yamada T, Ishida H: Correction to: Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan. International journal of clinical oncology. 2024.10; 29 (10): 1432-1434. ( PubMed , DOI )

  11. Katsuta L, Fujioka T, Kubota K, Mori M, Yamaga E, Yashima Y, Sato A, Adachi M, Ishiba T, Oda G, Nakagawa T, Tateishi U: Comparison of state-of-the-art biopsy systems for ultrasound-guided breast biopsy using a chicken breast phantom. Journal of medical ultrasonics (2001). 2024.08; 51 (4): 627-633. ( PubMed , DOI )

  12. Adachi M, Fujioka T, Ishiba T, Nara M, Maruya S, Hayashi K, Kumaki Y, Yamaga E, Katsuta L, Hao D, Hartman M, Mengling F, Oda G, Kubota K, Tateishi U: AI Use in Mammography for Diagnosing Metachronous Contralateral Breast Cancer. Journal of imaging. 2024.08; 10 (9): ( PubMed , DOI )

  13. Aruga, T; Iwatsuki, N: Exhaustive Enumeration of Spatial Prime Structures MACHINES. 2024.08; 12 (8): ( DOI )

  14. Adachi M, Ishiba T, Maruya S, Hayashi K, Kumaki Y, Oda G, Aruga T: Relationship between Volpara Density Grade and Compressed Breast Thickness in Japanese Patients with Breast Cancer. Diagnostics (Basel, Switzerland). 2024.07; 14 (15): ( PubMed , DOI )

  15. Toshiyuki Ishiba, Hirohiko Ishida, Michiaki Inoue, Yuki Tazoe, Mami Sakai, Yuki Fujita, Hiroko Kida, Taijiro Kosaka, Sakiko Ishihara, Miyako Nara, Mio Adachi, Chiaki Saita, Risa Goto, Naoko Iwamoto, Noriko Nakatsugawa, Masakazu Toi, Tomoyuki Aruga: Deodorant pad for ulcerated breast cancer: safety and efficacy. BMJ Support Palliat Care. 2024.07; 14 (e2): ( PubMed , DOI )

  16. Saldajeno DP, Kawaoka S, Masuda N, Tanaka S, Bando H, Nishimura T, Kadoya T, Yamanaka T, Imoto S, Velaga RM, Tamura N, Aruga T, Ikeda K, Fukui Y, Maeshima Y, Takada M, Suzuki E, Ueno T, Ogawa S, Haga H, Ohno S, Morita S, Kawaguchi K, Toi M: Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients. British journal of cancer. 2024.04; 130 (6): 1023-1035. ( PubMed , DOI )

  17. Sato A, Fujioka T, Onishi I, Yamaga E, Katsuta L, Kubota K, Kumaki Y, Ishiba T, Oda G, Tateishi U: Arterial Calcification Disappearance in Breast Imaging: A Key Indicator for Transition to Invasive Ductal Carcinoma. Diagnostics (Basel, Switzerland). 2024.03; 14 (7): ( PubMed , DOI )

  18. Nara M, Fujioka T, Mori M, Aruga T, Tateishi U: Correction to: Prediction of breast cancer risk by automated volumetric breast density measurement. Japanese journal of radiology. 2024.02; 42 (4): 435. ( PubMed , DOI )

  19. Sakai Takehiko, Kutomi Goro, Shien Tadahiko, Asaga Sota, Aruga Tomoyuki, Ishitobi Makoto, Kuba Sayaka, Sawaki Masataka, Terata Kaori, Tomita Koichi, Yamauchi Chikako, Yamamoto Yutaka, Iwata Hiroji, Saji Shigehira, The Japanese Breast Cancer Society: 日本乳癌学会による乳癌診療ガイドライン2022年版　外科療法(The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition) Breast Cancer. 2024.01; 31 (1): 1-7. ( ichushi )

  20. Sakai T, Kutomi G, Shien T, Asaga S, Aruga T, Ishitobi M, Kuba S, Sawaki M, Terata K, Tomita K, Yamauchi C, Yamamoto Y, Iwata H, Saji S: The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition. Breast cancer (Tokyo, Japan). 2024.01; 31 (1): 1-7. ( PubMed , DOI )

  21. Adachi M, Oda G, Hara M, Kumaki Y, Fujioka T, Ishiba T, Tateishi U: A Case of Autoimmune Neutropenia in a Patient Undergoing Breast Cancer Surgery. Case reports in surgery. 2024; 2024 5354241. ( PubMed , DOI )

  22. Adachi M, Oda G, Hara M, Kumaki Y, Fujioka T, Ishiba T, Tateishi U: A Case of Autoimmune Neutropenia in a Patient Undergoing Breast Cancer Surgery. Case reports in surgery. 2024; 2024 5354241. ( PubMed , DOI )

  23. A Case of Autoimmune Neutropenia in a Patient Undergoing Breast Cancer Surgery. 2024; 2024 5354241. ( PubMed , DOI )

  1. Zama S, Fujioka T, Yamaga E, Kubota K, Mori M, Katsuta L, Yashima Y, Sato A, Kawauchi M, Higuchi S, Kawanishi M, Ishiba T, Oda G, Nakagawa T, Tateishi U: Clinical Utility of Breast Ultrasound Images Synthesized by a Generative Adversarial Network. Medicina (Kaunas, Lithuania). 2023.12; 60 (1): ( PubMed , DOI )

  2. Takayama Shin, Kinoshita Takayuki, Shiino Sho, Jimbo Kenjiro, Watanabe Ken-ichi, Fujisawa Tomomi, Yamamoto Naohito, Onishi Tatsuya, Shien Tadahiko, Ito Mitsuya, Takahashi Mina, Futamura Manabu, Aruga Tomoyuki, Kaneko Koji, Suto Akihiko: 患者申出療養制度下における早期乳癌へのラジオ波熱焼灼療法の安全性と有効性に関する多施設共同研究(PO-RAFAELO研究)(Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy(PO-RAFAELO) Study under the Patient-proposed Health Services) JMA Journal. 2023.10; 6 (4): 505-512. ( ichushi )

  3. Ishiba Toshiyuki, Nishibuchi Ikuno, Hara Fumikata, Shikama Naoto, Shien Tadahiko, Iwata Hiroji: Metastasis-directed therapy for oligometastases in breast cancer(タイトル和訳中) Japanese Journal of Clinical Oncology. 2023.10; 53 (10): 893-898. ( ichushi )

  4. Sasada Shinsuke, Kondo Naoto, Hashimoto Hiroya, Takahashi Yuko, Terata Kaori, Kida Kumiko, Sagara Yasuaki, Ueno Takayuki, Anan Keisei, Suto Akihiko, Kanbayashi Chizuko, Takahashi Mina, Nakamura Rikiya, Ishiba Toshiyuki, Tsuneizumi Michiko, Nishimura Seiichiro, Naito Yoichi, Hara Fumikata, Shien Tadahiko, Iwata Hiroji: Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer. Breast Cancer Res Treat. 2023.09; ( PubMed , DOI )

  5. Ishiba Toshiyuki, Nishibuchi Ikuno, Hara Fumikata, Shikama Naoto, Shien Tadahiko, Iwata Hiroji: Metastasis-directed therapy for oligometastases in breast cancer. Jpn J Clin Oncol. 2023.07; ( PubMed , DOI )

  6. Tamura Taichi, Ikegami Masachika, Kanemasa Yusuke, Yomota Makiko, Furusawa Akiko, Otani Ryohei, Saita Chiaki, Yonese Ichiro, Onishi Tomoko, Kobayashi Hiroshi, Akiyama Toru, Shimoyama Tatsu, Aruga Tomoyuki, Yamaguchi Tatsuro: 日本における包括的ゲノムプロファイリングの遅延による選択バイアス(Selection bias due to delayed comprehensive genomic profiling in Japan) Cancer Science. 2023.03; 114 (3): 1015-1025. ( ichushi )

  7. Nara Miyako, Fujioka Tomoyuki, Mori Mio, Aruga Tomoyuki, Tateishi Ukihide: Prediction of breast cancer risk by automated volumetric breast density measurement Japanese Journal of Radiology. 2023.01; 41 (1): 54-62. ( ichushi )

  8. Iwata Hiroji, Nakamura Rikiya, Masuda Norikazu, Yamashita Toshinari, Yamamoto Yutaka, Kobayashi Kokoro, Tsurutani Junji, Iwasa Tsutomu, Yonemori Kan, Tamura Kenji, Aruga Tomoyuki, Tokunaga Eriko, Kaneko Koji, Lee Min-Jung, Yuno Akira, Kawabata Azusa, Seike Toshihiro, Kaneda Ayumi, Nishimura Yozo, Trepel Jane B., Saji Shigehira: 進行性または再発性乳癌に対するエンチノスタット+エキセメスタンの有効性と探索的バイオマーカー解析　第II相無作為化比較試験(Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial) Japanese Journal of Clinical Oncology. 2023.01; 53 (1): 4-15. ( ichushi )

  9. Iwata H, Nakamura R, Masuda N, Yamashita T, Yamamoto Y, Kobayashi K, Tsurutani J, Iwasa T, Yonemori K, Tamura K, Aruga T, Tokunaga E, Kaneko K, Lee MJ, Yuno A, Kawabata A, Seike T, Kaneda A, Nishimura Y, Trepel JB, Saji S: Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial. Japanese journal of clinical oncology. 2023.01; 53 (1): 4-15. ( PubMed , DOI )

  1. Aogi K, Watanabe K, Kitada M, Sangai T, Ohtani S, Aruga T, Kawaguchi H, Fujisawa T, Maeda S, Morimoto T, Sato N, Takao S, Morita S, Masuda N, Toi M, Ohno S: Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19). International journal of clinical oncology. 2022.11; 27 (11): 1793. ( PubMed , DOI )

  2. Aruga T, Doihara H, Yanagita Y, Ishida T, Yamashita T, Uehara K, Taira T, Tsurutani J, Takeshita T, Tsuyuki S, Kaneko K, Ohtake T, Yamaguchi Y, Hara Y, Saji S: Evaluation of a novel medical device for pegfilgrastim administration. Cancer science. 2022.05; 113 (5): 1763-1770. ( PubMed , DOI )

  3. Nara, M; Ishihara, S; Kitano, A; Tamura, N; Aruga, T; Kobayashi, D; Nakamura, S; Yamauchi, H: Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis BREAST CANCER. 2022.05; 29 (3): 394-401. ( PubMed , DOI )

  4. Nara Miyako, Ishihara Sakiko, Kitano Atsuko, Tamura Nobuko, Aruga Tomoyuki, Kobayashi Daiki, Nakamura Seigo, Yamauchi Hideko: BRCA変異キャリアにおける放射線療法併用乳房温存手術は同側乳房腫瘍の再発を有意に増加させるか　システマティックレビューとメタアナリシス(Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis) Breast Cancer. 2022.05; 29 (3): 394-401. ( ichushi )

  5. Aruga Tomoyuki, Doihara Hiroyoshi, Yanagita Yasuhiro, Ishida Takanori, Yamashita Toshinari, Uehara Kanou, Taira Tetsuhiko, Tsurutani Junji, Takeshita Takashi, Tsuyuki Shigeru, Kaneko Koji, Ohtake Tohru, Yamaguchi Yusuke, Hara Yui, Saji Shigehira: ペグフィルグラスチム投与用の新規医療デバイスの評価(Evaluation of a novel medical device for pegfilgrastim administration) Cancer Science. 2022.05; 113 (5): 1763-1770. ( ichushi )

  6. Saita Chiaki, Aruga Tomoyuki, Adachi Mio, Kumaki Yuichi, Iwamoto Naoko, Yonekura Rika, Nakatsugawa Noriko, Inokuchi Takuhiko, Ishiba Toshiyuki, Honda Yayoi, Yamaguchi Tatsuro: BRCA1 c.5332G>Aの生殖細胞系列バリアントは遺伝性乳癌卵巣癌症候群の臨床的特徴を有する(Germline variant of BRCA1 c.5332G>A has clinical features of hereditary breast and ovarian cancer syndrome) International Cancer Conference Journal. 2022.01; 11 (1): 12-16. ( ichushi )

  7. Ishiba Toshiyuki, Aruga Tomoyuki, Miyamoto Hiromi, Ishihara Sakiko, Nara Miyako, Adachi Mio, Kumaki Yuichi, Saita Chiaki, Onishi Mai, Goto Risa, Iwamoto Naoko, Yonekura Rika, Honda Yayoi, Fujii Miwako, Tomita Shoichi, Horiguchi Shinichiro, Oda Goshi, Nakagawa Tsuyoshi, Fujioka Tomoyuki, Terao Yasunobu: 術前補助化学療法後の即時乳房再建術の短期および長期転帰(Short- and long-term outcomes of immediate breast reconstruction surgery after neoadjuvant chemotherapy) Surgery Today. 2022.01; 52 (1): 129-136. ( ichushi )

  8. Germline variant of BRCA1 c.5332G>A has clinical features of hereditary breast and ovarian cancer syndrome. 2022.01; 11 (1): 12-16. ( PubMed , DOI )

  1. Tokisawa Hiromi, Aruga Tomoyuki, Kumaki Yuichi, Iwamoto Naoko, Yonekura Rika, Ishiba Toshiyuki, Honda Yayoi, Suzuki Mizuka: Metastasis of breast cancer to liver through direct lymphatic drainage: a case report. J Int Med Res. 2021.12; 49 (12): 3000605211064793. ( PubMed , DOI )

  2. Tokisawa Hiromi, Aruga Tomoyuki, Honda Yayoi, Ishiba Toshiyuki, Yonekura Rika, Iwamoto Naoko, Kumaki Yuichi, Tomita Shoichi, Fujii Miwako, Terao Yasunobu: Safety and Effectiveness of Areola-sparing Mastectomy for Breast Cancer With Intraductal Lesions. Anticancer Res. 2021.11; 41 (11): 5723-5728. ( PubMed , DOI )

  3. 乳癌治療におけるデエスカレーションとエスカレーション-さらなる個別化- HER2陽性乳癌に対する根治的化学療法+放射線療法の可能性 2021.10; 59回 SY3-2. ( ichushi )

  4. Tokunaga E, Masuda N, Yamamoto N, Iwata H, Bando H, Aruga T, Ohtani S, Fujisawa T, Takano T, Inoue K, Suganuma N, Takada M, Aogi K, Sakurai K, Shigematsu H, Kuroi K, Haga H, Ohno S, Morita S, Toi M: Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study). Cancers. 2021.08; 13 (16): ( PubMed , DOI )

  5. Iwamoto N, Nara M, Horiguchi SI, Aruga T: Surgical upstaging rates in patients meeting the eligibility for active surveillance trials. Japanese journal of clinical oncology. 2021.08; 51 (8): 1219-1224. ( PubMed , DOI )

  6. A Case of Adenomyoepithelioma With a Pleomorphic Adenoma-Like Component of the Male Breast. 2021.08; 29 (5): 538-542. ( PubMed , DOI )

  7. Iwamoto Naoko, Nara Miyako, Horiguchi Shin-ichiro, Aruga Tomoyuki: 積極的サーベイランス試験の適格性を満たす患者における外科手術時アップステージ率(Surgical upstaging rates in patients meeting the eligibility for active surveillance trials) Japanese Journal of Clinical Oncology. 2021.08; 51 (8): 1219-1224. ( ichushi )

  8. Aogi Kenjiro, Watanabe Kenichi, Kitada Masahiro, Sangai Takashi, Ohtani Shoichiro, Aruga Tomoyuki, Kawagichi Hidetoshi, Fujisawa Tomomi, Maeda Shigeto, Morimoto Takashi, Sato Nobuaki, Takao Shintaro, Morita Satoshi, Masuda Norikazu, Toi Masakazu, Ohno Shinji: HER2陰性再発乳癌に対するファーストラインまたはセカンドライン化学療法としてのエリブリンの臨床的有用性　無作為化第II相試験(JBCRG-19)(Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study(JBCRG-19)) International Journal of Clinical Oncology. 2021.07; 26 (7): 1229-1236. ( ichushi )

  9. Masuda N, Bando H, Yamanaka T, Kadoya T, Takahashi M, Nagai SE, Ohtani S, Aruga T, Suzuki E, Kikawa Y, Yasojima H, Kasai H, Ishiguro H, Kawabata H, Morita S, Haga H, Kataoka TR, Uozumi R, Ohno S, Toi M: Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial. Breast cancer research and treatment. 2021.07; 188 (1): 117-131. ( PubMed , DOI )

  10. Aogi K, Watanabe K, Kitada M, Sangai T, Ohtani S, Aruga T, Kawaguchi H, Fujisawa T, Maeda S, Morimoto T, Sato N, Takao S, Morita S, Masuda N, Toi M, Ohno S: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19). International journal of clinical oncology. 2021.07; 26 (7): 1229-1236. ( PubMed , DOI )

  11. Aogi K, Watanabe K, Kitada M, Sangai T, Ohtani S, Aruga T, Kawagichi H, Fujisawa T, Maeda S, Morimoto T, Sato N, Takao S, Morita S, Masuda N, Toi M, Ohno S: Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19). International journal of clinical oncology. 2021.07; 26 (7): 1237. ( PubMed , DOI )

  12. Fujioka Tomoyuki, Mori Mio, Kubota Kazunori, Yamaga Emi, Yashima Yuka, Oda Goshi, Nakagawa Tsuyoshi, Onishi Iichiroh, Ishiba Toshiyuki, Tateishi Ukihide: Clinical Usefulness of Ultrasound-Guided Fine Needle Aspiration and Core Needle Biopsy for Patients with Axillary Lymphadenopathy MEDICINA-LITHUANIA. 2021.07; 57 (7): ( PubMed , DOI )

  13. Ishiba Toshiyuki, Aruga Tomoyuki, Miyamoto Hiromi, Ishihara Sakiko, Nara Miyako, Adachi Mio, Kumaki Yuichi, Saita Chiaki, Onishi Mai, Goto Risa, Iwamoto Naoko, Yonekura Rika, Honda Yayoi, Fujii Miwako, Tomita Shoichi, Horiguchi Shinichiro, Oda Goshi, Nakagawa Tsuyoshi, Fujioka Tomoyuki, Terao Yasunobu: Short- and long-term outcomes of immediate breast reconstruction surgery after neoadjuvant chemotherapy. Surg Today. 2021.06; 52 (1): 129-136. ( PubMed , DOI )

  14. Yabe Sakiko, Nakagawa Tsuyoshi, Oda Goshi, Ishiba Toshiyuki, Aruga Tomoyuki, Fujioka Tomoyuki, Mori Mio, Kubota Kazunori, Uetake Hiroyuki: Association between skin flap necrosis and sarcopenia in patients who underwent total mastectomy ASIAN JOURNAL OF SURGERY. 2021.02; 44 (2): 465-470. ( PubMed , DOI )

  1. Yap Yoon-Sim, Chiu Joanne, Ito Yoshinori, Ishikawa Takashi, Aruga Tomoyuki, Kim Seung Jin, Toyama Tatsuya, Saeki Toshiaki, Saito Mitsue, Gounaris Ioannis, Su Fei, Ji Yan, Han Yu, Gazdoiu Mihaela, Masuda Norikazu: アジア人進行乳癌女性に対するCDK4/6阻害薬ribociclibと内分泌治療の併用(Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer) Cancer Science. 2020.09; 111 (9): 3313-3326. ( ichushi )

  2. Iwamoto N, Aruga T, Asami H, Horiguchi SI: False-negative ultrasound-guided fine-needle aspiration of axillary lymph nodes in breast cancer patients. Cytopathology : official journal of the British Society for Clinical Cytology. 2020.09; 31 (5): 463-467. ( PubMed , DOI )

  3. Ishiba Tohiyuki, Aruga Tomoyuki, Nara Miyako, Yabe Sakiko, Saita Chiaki, Onishi Mai, Iwamoto Naoko, Yonekura Rika, Miyamoto Hiromi, Honda Yayoi, Oda Goshi, Nakagawa Tsuyoshi, Nakanishi Akira, Uetake Hiroyuki, Miki Yoshio: Calretinin can be the specific marker for phyllodes tumor CANCER RESEARCH. 2020.08; 80 (16): ( DOI )

  4. Oda G, Nakagawa T, Ogawa A, Kumaki Y, Hosoya T, Sugimoto H, Ishiba T, Mio M, Fujioka T, Kubota K, Onishi I, Uetake H: Predictors for upstaging of ductal carcinoma in situ (DCIS) to invasive carcinoma in non-mass-type DCIS. Molecular and clinical oncology. 2020.07; 13 (1): 67-72. ( PubMed , DOI )

  5. Goto Risa, Hirota Yuko, Aruga Tomoyuki, Horiguchi Shinichiro, Miura Sakiko, Nakamura Seigo, Takimoto Masafumi: 同時性両側性乳癌患者におけるFoxP3陽性腫瘍浸潤リンパ球の数(The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer) Breast Cancer. 2020.07; 27 (4): 586-593. ( ichushi )

  6. Goto R, Hirota Y, Aruga T, Horiguchi S, Miura S, Nakamura S, Takimoto M: The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer. Breast cancer (Tokyo, Japan). 2020.07; 27 (4): 586-593. ( PubMed , DOI )

  7. Iwamoto Naoko, Miyamoto Hiromi, Horiguchi Shinichiro, Honda Yayoi, Aruga Tomoyuki: Z1071臨床試験による判定基準の適用　初回診断でリンパ節転移陽性と判定された乳癌患者に対する術前化学療法後の超音波検査による腋窩リンパ節分類(Application of the Z1071 criteria: classification of axillary lymph nodes on ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer) Journal of Medical Ultrasonics. 2020.04; 47 (2): 299-303. ( ichushi )

  8. Iwase M, Ando M, Aogi K, Aruga T, Inoue K, Shimomura A, Tokunaga E, Masuda N, Yamauchi H, Yamashita T, Iwata H: Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer. Breast cancer research and treatment. 2020.04; 180 (3): 687-694. ( PubMed , DOI )

  9. Iwamoto N, Miyamoto H, Horiguchi S, Honda Y, Aruga T: Application of the Z1071 criteria: classification of axillary lymph nodes on ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer. Journal of medical ultrasonics (2001). 2020.04; 47 (2): 299-303. ( PubMed , DOI )

  10. Iwamoto N, Aruga T, Horiguchi S, Saita C, Onishi M, Goto R, Ishiba T, Honda Y, Miyamoto H, Kuroi K: Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy. Surgery today. 2020.02; 50 (2): 178-184. ( PubMed , DOI )

  11. Iwamoto Naoko, Aruga Tomoyuki, Horiguchi Shinichiro, Saita Chiaki, Onishi Mai, Goto Risa, Ishiba Toshiyuki, Honda Yayoi, Miyamoto Hiromi, Kuroi Katsumasa: ネオアジュバント化学療法を受けたリンパ節陽性乳癌の腋窩病理学的完全寛解の予測因子(Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy) Surgery Today. 2020.02; 50 (2): 178-184. ( ichushi )

  1. Fujioka Tomoyuki, Mori Mio, Kubota Kazunori, Kikuchi Yuka, Katsuta Leona, Kasahara Mai, Oda Goshi, Ishiba Toshiyuki, Nakagawa Tsuyoshi, Tateishi Ukihide: 定性的および定量的評価による、良性病変と悪性病変の鑑別における乳房腫瘤のstrain elastographyとshear wave elastographyの同時比較(Simultaneous comparison between strain and shear wave elastography of breast masses for the differentiation of benign and malignant lesions by qualitative and quantitative assessments) Breast Cancer. 2019.11; 26 (6): 792-798. ( ichushi )

  2. Iwamoto N, Aruga T, Horiguchi S, Asami H, Saita C, Onishi M, Goto R, Ishiba T, Honda Y, Miyamoto H, Kuroi K: Ultrasound-guided fine-needle aspiration of axillary lymph nodes in breast cancer: Diagnostic accuracy and role in surgical management. Diagnostic cytopathology. 2019.08; 47 (8): 788-792. ( PubMed , DOI )

  3. Fujioka T, Mori M, Kubota K, Kikuchi Y, Katsuta L, Kasahara M, Oda G, Ishiba T, Nakagawa T, Tateishi U: Simultaneous comparison between strain and shear wave elastography of breast masses for the differentiation of benign and malignant lesions by qualitative and quantitative assessments. Breast cancer (Tokyo, Japan). 2019.06; ( PubMed , DOI )

  4. Fujioka Tomoyuki, Kubota Kazunori, Mori Mio, Kikuchi Yuka, Katsuta Leona, Kasahara Mai, Oda Goshi, Ishiba Toshiyuki, Nakagawa Tsuyoshi, Tateishi Ukihide: convolutional neural networkによる深層学習を用いた乳房超音波検査における良性および悪性乳房腫瘤の判別(Distinction between benign and malignant breast masses at breast ultrasound using deep learning method with convolutional neural network) Japanese Journal of Radiology. 2019.06; 37 (6): 466-472. ( ichushi )

  5. Fujioka T, Kubota K, Mori M, Kikuchi Y, Katsuta L, Kasahara M, Oda G, Ishiba T, Nakagawa T, Tateishi U: Distinction between benign and malignant breast masses at breast ultrasound using deep learning method with convolutional neural network. Japanese journal of radiology. 2019.03; ( PubMed , DOI )

  1. Iwamoto Naoko, Aruga Tomoyuki, Kuroi Katsumasa, Saita Chiaki, Onishi Mai, Goto Risa, Ishiba Toshiyuki, Honda Yayoi, Miyamoto Hiromi: 複数回の治療を受けた転移性乳癌患者に対するパルボシクリブの有効性および毒性(Efficacy and toxicity of palbociclib in heavily treated patients with metastatic breast cancer) Annals of Cancer Research and Therapy. 2018.12; 26 (2): 105-109. ( ichushi )

  2. Imataka G, Yamaguchi T, Ishii J, Ogino K, Okamoto K, Tsuchioka T, Yoshihara S: MERS associated with bacterial translocation in a pediatric patient with congenital portal vein hypoplasia: A case report Experimental and Therapeutic. 2018.10; 16 (4): 2831-2834. ( PubMed , DOI )

  3. Fujioka T, Kubota K, Kikuchi Y, Tsuchiya J, Tateishi U, Kasaharak M, Oda G, Ishiba T, Nakagawa T: The feasibility of using 18F-FDG-PET/CT in patients with mucinous breast carcinoma. Nuclear medicine communications. 2018.09; ( PubMed , DOI )

  4. Efficacy and toxicity of palbociclib in heavily treated patients with metastatic breast cancer 2018.08; 26 (2): 105-109. ( DOI )

  5. Saita C, Yamaguchi T, Horiguchi SI, Yamada R, Takao M, Iijima T, Wakaume R, Aruga T, Tabata T, Koizumi K: Tumor development in Japanese patients with Lynch syndrome. PloS one. 2018; 13 (4): e0195572. ( PubMed , DOI )

  1. Ishiba T, Nakagawa T, Sato T, Nagahara M, Oda G, Sugimoto H, Kasahara M, Hosoya T, Kubota K, Fujioka T, Danenberg P, Danenberg K, Uetake H: Efficiency of fluorodeoxyglucose positron emission tomography/computed tomography to predict prognosis in breast cancer patients received neoadjuvant chemotherapy. SpringerPlus. 2015; 4 817. ( PubMed , DOI )

  1. Ishiba T, Nagahara M, Nakagawa T, Sato T, Ishikawa T, Uetake H, Sugihara K, Miki Y, Nakanishi A: Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion. Scientific reports. 2014.11; 4 7069. ( PubMed , DOI )

  1. Sakiko Yabe, Naoko Iwamoto, Takuhiko Inokuchi, Miyako Nara, Chiaki Saita, Mai Onishi, Risa Goto, Rika Yonekura, Toshiyuki Ishiba, Yayoi Honda, Hiromi Miyamoto, Tomoyuki Aruga: [A Case Report on the Effectiveness of Olaparib in a Patient with Recurrent Breast Cancer with Human Immunodeficiency Virus Infection]. Gan to kagaku ryoho. Cancer & chemotherapy. 2020.07; 47 (7): 1089-1092. ( PubMed )

  1. Naoko Iwamoto, Tomoyuki Aruga, Hiromi Miyamoto, Chiaki Saita, Mai Onishi, Risa Goto, Toshiyuki Ishiba, Yayoi Honda, Katsumasa Kuroi: [Toxicity of Palbociclib in Patients Aged 70 Years and Older with Metastatic Breast Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 2019.07; 46 (7): 1137-1140. ( PubMed )

  1. Toshiyuki Ishiba, Andreas-Claudius Hoffmann, Joshua Usher, Yahya Elshimali, Todd Sturdevant, Mai Dang, Yolanda Jaimes, Rama Tyagi, Ronald Gonzales, Mary Grino, Jacek K Pinski, Afsaneh Barzi, Luis E Raez, Wilfried E Eberhardt, Dirk Theegarten, Heinz-Josef Lenz, Hiroyuki Uetake, Peter V Danenberg, Kathleen Danenberg: Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types. Biochemical and biophysical research communications. 2018.06; 500 (3): 621-625. ( PubMed , DOI )

To the head of this page.▲